Ronnie Levy

Impliant, Inc. develops novel spine arthroplasty solutions for motion preservation. The company was founded by Amiram Steinberg and Uri Arnin in 2004 and it is headquartered in Princeton, NJ.

Impliant is engaged in the development of novel spine arthroplasty solutions for motion preservation. The Company's flagship device the TOPS Systems is a total posterior motion preservation system for patients suffering from mild to moderate spinal stenosis, with or without grade I spondylolisthesis and facet arthrosis. Impliant has the longest and largest series of patients for this indication with a motion preservation device. The Company's management team has extensive experience commercializing new technologies, including fusion and total disc replacement devices. Impliant raised its first round of venture capital investment in 2000 and remains a privately held company until today.

Impliant is engaged in the development of novel spine arthroplasty solutions for motion preservation. The Company's flagship device the TOPS Systems is a total posterior motion preservation system for patients suffering from mild to moderate spinal stenosis, with or without grade I spondylolisthesis and facet arthrosis. Impliant has the longest and largest series of patients for this indication with a motion preservation device. The Company's management team has extensive experience commercializing new technologies, including fusion and total disc replacement devices. Impliant raised its first round of venture capital investment in 2000 and remains a privately held company until today.

Impliant is engaged in the development of novel spine arthroplasty solutions for motion preservation. The Company's flagship device the TOPS Systems is a total posterior motion preservation system for patients suffering from mild to moderate spinal stenosis, with or without grade I spondylolisthesis and facet arthrosis. Impliant has the longest and largest series of patients for this indication with a motion preservation device. The Company's management team has extensive experience commercializing new technologies, including fusion and total disc replacement devices. Impliant raised its first round of venture capital investment in 2000 and remains a privately held company until today.